Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

被引：0
|
作者：
Akiko Ogiya
Kieko Yamazaki
Rie Horii
Tadahiko Shien
Yoshiya Horimoto
Norikazu Masuda
Touko Inao
Mitsuchika Hosoda
Naoko Ishida
Tomofumi Osako
Masato Takahashi
Yumi Endo
Yuichiro Miyoshi
Hiroyuki Yasojima
Nobumoto Tomioka
Hiroko Yamashita
机构：
[1] Japanese Foundation for Cancer Research,Breast Surgical Oncology, Cancer Institute Hospital
[2] Cancer Institute of the Japanese Foundation for Cancer Research,Division of Pathology
[3] Okayama University Hospital,Breast and Endocrine Surgery
[4] Juntendo University School of Medicine,Department of Breast Oncology
[5] NHO Osaka National Hospital,Department of Surgery, Breast Oncology
[6] Graduate School of Medical Science Kumamoto University,Department of Breast and Endocrine Surgery
[7] Hokkaido University Hospital,Breast Surgery
[8] Kumamoto City Hospital,Department of Breast and Endocrine Surgery
[9] Kumamoto Shinto General Hospital,Department of Breast Surgery
[10] NHO Hokkaido Cancer Center,Department of Oncology, Immunology and Surgery
[11] Nagoya City University Graduate School of Medical Sciences,undefined
来源：
Breast Cancer | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：642 / 642
相关论文
共 50 条
  • [21] EndoPredict(R) in early hormone receptor-positive, HER2-negative breast cancer
    Almstedt, K.
    Mendoza, S.
    Otto, M.
    Battista, M. J.
    Steetskamp, J.
    Heimes, A. S.
    Krajnak, S.
    Poplawski, A.
    Gerhold-Ay, A.
    Hasenburg, A.
    Denkert, C.
    Schmidt, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (01) : 137 - 146
  • [22] The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer
    Rojas, Kristin E.
    Manasseh, Donna-Marie
    Rojas, Mary
    Mattocks, Andrea
    Portnow, Leah
    Kantharia, Sarah
    Zelenko, Natalie
    Giuliano, Christina
    Borgen, Patrick, I
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (01) : 79 - 83
  • [23] The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients
    Reinert, Tomas
    do Rego, Fernanda Orpinelli
    Silva, Matheus Costa e
    Rodrigues, Amanda Muniz
    Koyama, Fernanda Christtanini
    Goncalves, Aline Coelho
    Pauletto, Maiane Maria
    de Carvalho Oliveira, Leandro Jonata
    de Resende, Cristiano Augusto Andrade
    Landeiro, Luciana Castro Garcia
    Barrios, Carlos Henrique
    Mano, Max Senna
    Dienstmann, Rodrigo
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] Immunotherapy for hormone receptor-positive HER2-negative breast cancer
    Cardoso, Fatima
    Hirshfield, Kim M.
    Kraynyak, Kimberly A.
    Tryfonidis, Konstantinos
    Bardia, Aditya
    NPJ BREAST CANCER, 2024, 10 (01)
  • [25] Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer
    Sparano, Joseph A.
    O'Neill, Anne
    Graham, Noah
    Northfelt, Donald W.
    Dang, Chau T.
    Wolff, Antonio C.
    Sledge, George W.
    Miller, Kathy D.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [26] Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer
    Joseph A. Sparano
    Anne O’Neill
    Noah Graham
    Donald W. Northfelt
    Chau T. Dang
    Antonio C. Wolff
    George W. Sledge
    Kathy D. Miller
    npj Breast Cancer, 8
  • [27] Association of Endocrine Therapy with Survival for Patients with Small, Hormone Receptor-Positive, HER2-Negative, Breast Cancer
    Ma, S. J.
    Oladeru, O. T.
    Sood, A. J.
    Mikucki, M.
    Farrugia, M. K.
    Singh, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E74 - E74
  • [28] Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer
    Basaran, Gul A.
    Twelves, Chris
    Dieras, Veronique
    Cortes, Javier
    Awada, Ahmad
    CANCER TREATMENT REVIEWS, 2018, 63 : 144 - 155
  • [29] Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study
    Luen, S. J.
    Asher, R.
    Lee, C. K.
    Savas, P.
    Kammler, R.
    Dell'Orto, P.
    Biasi, O. M.
    Demanse, D.
    Hackl, W.
    Thuerlimann, B.
    Viale, G.
    Di Leo, A.
    Colleoni, M.
    Regan, M. M.
    Loi, S.
    ANNALS OF ONCOLOGY, 2020, 31 (10) : 1359 - 1365
  • [30] FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Beaver, Julia A.
    Amiri-Kordestani, Laleh
    Charlab, Rosane
    Chen, Wei
    Palmby, Todd
    Tilley, Amy
    Zirkelbach, Jeanne Fourie
    Yu, Jingyu
    Liu, Qi
    Zhao, Liang
    Crich, Joyce
    Chen, Xiao Hong
    Hughes, Minerva
    Bloomquist, Erik
    Tang, Shenghui
    Sridhara, Rajeshwari
    Kluetz, Paul G.
    Kim, Geoffrey
    Ibrahim, Amna
    Pazdur, Richard
    Cortazar, Patricia
    CLINICAL CANCER RESEARCH, 2015, 21 (21) : 4760 - 4766
12345